Link to article: https://www.reuters.com/article/us-health-coronavirus-chile-vaccines/chile-peru-green-light-astrazeneca-covid-19-vaccine-trials-idUSKBN27K2O7
On Wednesday, November 4, 2020, Chilean President Sebastian Pinera announced that the country’s health regulator had approved clinical trials of AstraZeneca PLC’s COVID-19 vaccine. The United States and China are already in the midst of trials of prospective vaccines by Johnson & Johnson and Sinovac, respectively. In addition to these trials with AstraZeneca, Chile is in the process of buying up millions of doses of various COVID-19 vaccines from around the world, including those of Pfizer Inc, Germany’s BioNTech, Johnson & Johnson, and Sinovac.
Finding a reliable COVID-19 vaccine will take a great deal of collaboration among scientists and countries from all over the world. Perhaps the Chilean government’s reason for buying up so many doses of so many variations of the COVID vaccine is intended to not only equip its citizens with the tools they need to overcome the pandemic, but also to continue widespread vaccination testing to aid in research. By compiling the data from all of the vaccine trials and examining the successes and failures in each, world scientists will likely be able to develop a vaccine that is of optimal effectiveness, thereby helping to end the COVID-19 pandemic.
If this vaccine produced by these companies and countries is effective, they could lead the rest of the global community in vaccine production so the world can beat the pandemic. Especially if they find a vaccine, they can share their information with wealthier countries that will help fund the production and distribution of the vaccination world wide. These counties could also create an IGO that would help distribute the vaccine to smaller, poorer countries that may not be able to afford the vaccine for their citizens. The IGO could help strengthen allyships between countries that want to end the global pandemic so their country can continue to grow and so their struggle could come to an end.